#abrysvo

#abrysvo

Maternal RSV vaccination (Abrysvo) during pregnancy, combined with infant nirsevimab, substantially reduced infant hospitalizations, with an estimated 50% decline in Northern California.

Maternal Abrysvo vaccination during pregnancy significantly reduces newborn RSV risk, contributing to about a 50% decline in infant hospitalizations at Kaiser Permanente Northern California.